| Discuss | Index | Tracked By |
Traders Send Select Stem Cell Shares Soaring
OPXA JNJ ABT NBS GILD PSTI BCRX NVAX ATHX GERN OSIR CUR Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - February 08, 10:30AM from (www.tickerspy.com) The absence of notable news didn't stop speculators in the stem cell sector on Monday. Select stem cell more ...
Analyst Upgrades, Downgrades and Initiations: BBY, EXC, GPS, H, LEAP, MA, MOT, TAP ...
TAP STST GPS MOT JWN HOT MUR BBY MTH PFWD LEAP EXC MA PSTI XEC EDU SOL Linked by BloggingStocks ( track newsfeed | ignore newsfeed ) - February 05, 11:40AM from (www.bloggingstocks.com) Analyst Upgrades Wells Fargo upgraded MasterCard (MA) to outperform from market perform on valuation as more ...
ThermoGenesis Reports Significant Improvement in Sequential Financial Results for Second Quarter Fiscal 2010
KOOL Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - February 04, 04:00PM RANCHO CORDOVA, Calif., Feb. 4 /PRNewswire-FirstCall/ -- more ...
Slew of Stem Cell News Helps Sector Higher
NBS STEM GERN OPXA CYTX CUR ATHX Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - January 25, 11:37AM from (www.tickerspy.com) Volatile stem cell play Neostem (NBS) tested short-term resistance at the $2 mark with a 25% daily spike on Monday. more ...
Catching up with 2010's Wild Card Stocks
C STEM VG Linked by WallStNation.com ( track newsfeed | ignore newsfeed ) - January 17, 01:22PM from (wallstnation.com) Back in December WallStNation.com listed Vonage Holdings Corp. (NYSE:VG), StemCells, Inc. (NASDAQ:STEM) and Citigroup Inc. more ...
Geron (GERN): 'First in Class' in Stem Cell Research
GERN Linked by BloggingStocks ( track newsfeed | ignore newsfeed ) - January 15, 01:00PM from (www.bloggingstocks.com) "Geron (GERN) is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, more ...
DiagnoCure announces fourth quarter 2009 and year-end results
CUR Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - January 14, 04:44PM QUEBEC CITY, Jan. 14 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value more ...
Fat Gains for Select Stem Cell Stocks
PFE NBS KOOL STEM GERN OPXA CYTX PSTI CUR ATHX Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - January 08, 11:39AM from (www.tickerspy.com) Cytori Therapeutics (CYTX) led the stem cell sector on Friday. It's been a strong week for select stem more ...
DiagnoCure to host Q4 2009 and full year earnings conference call and webcast
CUR Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - January 05, 02:44PM Ticker Symbol: CUR QUEBEC CITY, Jan. 5 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life sciences more ...
Wild Card Stocks for 2010 under $3:
C STEM VG Linked by WallStNation.com ( track newsfeed | ignore newsfeed ) - December 24, 06:33PM from (wallstnation.com) If you only have few bucks floating around and want to try to catch the best bang for your buck in 2010, look no further more ...
Inflow-Outflow Data Could Be Bullish Equity Indicator
CMC PKE STT JBL ATHX Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - December 22, 04:55PM from (www.tickerspy.com) Stocks had another solid day, with the S&P pushing to a new closing yearly high. December has traditionally been more ...
Closing Bell: Decoupling of inverse dollar and stock relationship (POT, CHTT, ETFC, ATHX, V, BIIB)
CHTT POT BIIB ETFC ATHX V Linked by BloggingStocks ( track newsfeed | ignore newsfeed ) - December 21, 04:00PM from (www.bloggingstocks.com) Stocks had effectively no real market moving economic data to trade off of. We also saw a break-away from the inverse relationship more ...
Stem Cell Stocks Rise, Led By Athersys Inc.
PFE NBS KOOL STEM GERN ASTM OPXA CYTX PSTI CUR OSIR ATHX Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - December 21, 02:33PM from (247wallst.com) Stem cell stocks (tracked in Tickerspy's Stem Cell Stock's Index (*RXSTM) are up over 7% today, led by Athersys Inc (NASDAQ: more ...
A Slew of New Deals Move Pharma Stocks
CHTT LLY PFE WAG TEVA ISIS INCY OGXI SGEN SNY GSK ATHX Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - December 21, 10:17AM from (www.tickerspy.com) Some big names got into the action on Monday. A nearly $2 billion buyout and three new agreements are more ...
Opexa Therapeutics, Inc. Announces Closing of $5.1 Million Registered Direct Offering
OPXA Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - December 17, 08:30AM from (www.businesswire.com) Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis more ...
Huge Leaps for Small-Cap Pharma Plays
NABI AMGN MNKD DEPO GNBT CYTX ARRY CRIS JAZZ BIOD Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - December 15, 10:04AM from (www.tickerspy.com) Shares of Array BioPharma (ARRY) surged on Tuesday after the small-cap company signed a $60 million deal. more ...
Interim Data Lifts Geron, Stem Cell Rivals Mixed
KOOL STEM GERN ASTM OPXA CYTX Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - December 08, 09:36AM from (www.tickerspy.com) Geron (GERN) jumped on Tuesday following positive interim data in leukemia study. Geron announced the more ...
Top Day Trader Alerts
XLNX CELG GERN GMCR PEET DDRX YONG Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - December 08, 08:35AM from (247wallst.com) These are this Tuesday's top four day trader and active trader alert stories. We have more details and analysis via links to each story at VSInvestor.com: more ...
Closing Bell: No economic help today (CBST, AMZN, ABK, BAC, HUN, DD, STEM, STI)
DD BAC STI ABK STEM CBST AMZN HUN Linked by BloggingStocks ( track newsfeed | ignore newsfeed ) - December 03, 04:15PM from (www.bloggingstocks.com) The weekly jobless claims set the tone for a positive day, but the Obama speech comments today may have set the tone for more ...
Stem Cells Stocks Slow Down after Yesterday's Big Rally
STEM GERN ASTM OPXA Linked by WallStNation.com ( track newsfeed | ignore newsfeed ) - December 03, 01:11PM from (wallstnation.com) Yesterday after the announcement of the approval of 13 new human embryonic stem cell lines shares of StemCells, Inc. (NASDAQ:STEM), more ...
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2010 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|